To utilize this hypothetical miRNA-pathway regulation in understanding disease mechanisms, we used three different breast cancer datasets for the purpose of finding a consistent and robust pathway that stratifies patients into two groups, based on their Estrogen Receptor (ER) status. The gene discussed is ESR1; the disease is breast carcinoma.